Finally, we assessed how well machine learning models can discriminate between PD patients and non‐diseased individuals, between LRRK2 G2019S and wild‐type allele carriers, and between NMC individuals and LRRK2 G2019S patients based on the acquired urinary proteome profiles. Here, LRRK2 is linked to Parkinson disease.